Stock VRTX VERTEX PHARMACEUTICALS INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Vertex Pharmaceuticals Incorporated

Equities

VRTX

US92532F1003

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		Pre-market 07:05:00 am
455.3 USD +2.74% Intraday chart for Vertex Pharmaceuticals Incorporated 456.9 +0.34%
May. 31 BMO Capital Adjusts Price Target on Vertex Pharmaceuticals to $500 From $480 MT
May. 31 Vertex Pharmaceuticals Insider Sold Shares Worth $1,478,068, According to a Recent SEC Filing MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. VRTX Stock
  4. Revisions Vertex Pharmaceuticals Incorporated